Researchers evaluated the impact of different treatment modalities in the prevention of psoriatic arthritis (PsA). Biological agents were found more effective than methotrexate in preventing psoriatic ...

Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis. Risankizumab showed superior efficacy across multiple outcomes compared ...

For patients with psoriatic arthritis, bimekizumab was more effective for treating cutaneous symptoms compared with many other available treatments and ranked highly among currently approved ...

(HealthDay News) — Highly conservative use of the prostate-specific antigen (PSA) test and biopsy referral is necessary for PSA screening to be cost-effective, according to a study published online ...